Summary Slide.png (119.04 kB)
The Impact of OnabotulinumtoxinA vs Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine
figure
posted on 2020-09-30, 16:00 authored by Stephen D. Silberstein, Hans-Christoph Diener, David W. Dodick, Aubrey Manack Adams, Ronald E. DeGryse, Richard B. LiptonThe above Summary Slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.
